The Ibex rebounds ... although still concerned about the new strain of the virus

The European stock markets react after the sharp falls this Monday

Bolsamanía
Bolsamania | 22 dic, 2020 09:31
ep la bolsa de madrid un dia despues de la celebracion de elecciones en estados unidos en madrid
Eduardo Parra - Europa Press

The Ibex and the rest of the stock exchanges of the Old Continent, which this Monday fell very strongly due to the new strain of coronavirus in the United Kingdom and its isolation from Europe- rebound this Tuesday (Ibex: +0 , 76%. 7,849 points). Within the selective, the increases in Meliá, IAG or Bankinter stand out, while only two values ​​fell (Repsol and Cie).

IBEX 35
11.473,900
  • 0,33%38,20
  • Max: 11.485,70
  • Min: 11.446,20
  • Volume: -
  • MM 200 : 11.299,24
14:00 24/12/24

The new strain is highly contagious and, although the EMA (European Medicines Agency) has stated that there is no evidence that it is resistant to vaccines, this possibility is of particular concern.

On the other side of the Atlantic, the news is that the House of Representatives has already approved the new plan to help the economy of some 900bn dollars. The third and final calculation of GDP for the third quarter is published today there.

Returning to the Ibex and its technical aspect after the falls on Monday, when it fell 3%, the experts of Bolsamanía do not rule out that it extends the correction after pulverizing the short-term support located at 7,978 points. "We do not rule out seeing how it seeks support in the vicinity of the average of 200 sessions, an average that is in the vicinity of 7,200 points," explained the analysts at Bolsamanía.

From a business point of view, it is news that Endesa has announced 1,200 voluntary terminations in Spain at a cost of 390 million euros.

For its part, politically, attention remains on Brexit. In the opinion of the experts, it is now even more difficult to reach an agreement these days because the UK is focused on curbing the new strain of the virus. "In addition, we will follow the distribution of the Pfizer vaccine in the European Union after it was approved yesterday," Danske Bank experts say in their daily report.

contador